Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
BMJ Open|November 19, 2015
Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational studyDerek J Ward, Edward Hammond, Luan Linden-Phillips, et al.
Clinical Pharmacology in Drug Development|December 11, 2023
Population-Based Characterization of the Pharmacokinetics and Food Effect of ANAVEX3-71, a Novel Sigma-1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer DiseaseEmmanuel O Fadiran, Edward Hammond, James Tran, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 11, 2018
The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of actionMarina Weissmann, Udayan Bhattacharya, Sari Feld, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 20, 2014
Does access modality matter? Evaluation of validity in reusing clinical care dataChristopher P Danford, Monica M Horvath, W Edward Hammond, et al.
Cancer Research|June 28, 2014
Heparanase cooperates with Ras to drive breast and skin tumorigenesisIlanit Boyango, Uri Barash, Inna Naroditsky, et al.
Cancer Research|February 5, 2003
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteinsJ Blake Marriott, Ian A Clarke, Anna Czajka, et al.
Microvascular Research|March 31, 2005
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitroKeith Dredge, Rebecca Horsfall, Simon P Robinson, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2008
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cellsChristine Galustian, Brendan Meyer, Marie-Christine Labarthe, et al.
Rheumatology Advances in Practice|September 24, 2021
Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysisJulia Langham, Volkan Barut, Mihail Samnaliev, et al.
Cancer Research|August 8, 2015
Heparanase Enhances Tumor Growth and Chemoresistance by Promoting AutophagyAnna Shteingauz, Ilanit Boyango, Inna Naroditsky, et al.
Pageof 8